The STAR™ Tumor Ablation System delivers meaningful pain relief and localized tumor destruction in a single treatment, often in an outpatient setting. The STAR™ Tumor Ablation system is used for treating Metastatic Spinal Tumors with targeted RadioFrequency Ablation (t-RFA).

Expand your range of treatment options:
Any patient with focalized pain from a metastatic spinal tumor may be a candidate for t-RFA, several specific patient groups will likely benefit most from the procedure.

Patients Who Benefit from RF Spine Tumor Ablation with The STAR™ Tumor Ablation System

Patients with focal pain from metastatic spinal tumor(s) may be a candidate for treatment.

However, patients that are ideally suited include those with:

• Radio-resistant tumors
• Persistent and/or recurrent pain after radiation therapy
• Posterior vertebral body tumors
• Reached maximum radiation dose limit
• Focalized pain preventing immobilization for treatment with palliative radiation
• Cannot undergo other palliative treatments due to their concurrent systemic treatments or ongoing clinical trials
• Risk of myelosuppression